To formulate fast dissolving tablets of amlodipine besylate using co-processed superdisintigrant and evaluate the properties of fast dissolving tablets.
INTRODUCTION
Tablets have remained the most common dosage form by which medicaments are usually administered to patients because of their advantages over the other dosage forms. Tablet dosage forms are the most popular and preferred drug delivery systems in terms of precision of unit dose, low cost, patient compliance, and good physical and chemical stability. Tablets account for 70% -80% of all pharmaceutical dosage forms. (1) Hypertension is becoming an important public health challenge worldwide. Hypertension is one of the main risk factors for cardiovascular diseases, which is one of the leading causes of death in developed countries. (2) The relationship between blood pressure and risk of cardiovascular disease is continuous, consistent and independent of other risks. The higher the blood pressure, the greater is the chance of ischemic heart disease, stroke, heart failure and kidney diseases. Therefore prevention, detection, treatment and control of hypertension should receive high priority (3) . Many patients have difficulty to swallow tablets and hard gelatin capsules. This results in high incidence of noncompliance and ineffective therapy. (4) .There is unavailability of water during travelling, to overcome these problems fast dissolving tablet is emerged. FDT dissolves rapidly in the saliva without the need for water, faster the dissolution and provide quick onset of action. The bioavailability of drug is significantly enhanced by avoiding first pass hepatic metabolism than conventional tablets. (5) Amlodipine is a dihydropyridine calcium antagonist (calcium ion-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. It binds to both dihydropyridine and non dihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extra cellular calcium ions into these cells through specific ion channels. Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells. (6) Amlodipine is an ionized compound having ionization value 8.6 (pKa = 8.6)
.
The bioavailability of amlodipine besylate, the functionality of excipients is improved by coprocessed method. (8) Co-processing is based on the novel concept of two or more excipients interacting at the sub particle level, the objective of which is to provide a synergy of functionality improvement as well as masking the undesirable properties of individual Co-processing excipients lead to the formulation of excipient granules with superior properties, compared with physical mixtures of components or individual components, like improved flow properties, improved compressibility, better dilution potential, fill weight uniformity, and reduced lubricant sensitivity. (9, 10) .Several co-processed superdisintegrants are commercially available: Ludipress (lactose monohydrate, polyvinylpyrrolidone and crospovidone), Starlac (lactose and maize starch), Starcap 1500 (corn starch and pregelatinized starch), Ran Explo-C (microcrystalline cellulose, silica and crospovidone), Ran Explo-S (microcrystalline cellulose, silica and sodium starch glycolate), PanExcea MH300G (microcrystalline cellulose, hydroxy propyl methyl cellulose and crospovidone) (11) .
In present study, the preparation and evaluation of FDT by using co processed superdisintegrants containing crospovidone and sodium starch glycolate was studied. The reasons for selection of crospovidone are high capillary activity, pronounced hydration capacity and little tendency to form gels. (12, 13, 14) Sodium starch glycolate has high swelling capacity (15) . The concept of formulating fast dissolving tablets (FDT) of amlodipin besylate (anti-hypertensive) using co-processed superdisintegrants helps to increase the water uptake with shortest wetting time and thereby decrease the disintegration time of the tablets by simple and cost effective direct compression technique.
MATERIALS AND METHODS

Materials
Amlodipine besylate is procured by wockhardt Aurangabad, crosspovidone (polyplasdone) and sodium starch glycolate are gifted by Sai Tech Lab. Sinner (Nasik), Microcrystalline Cellulose, Manitol Isopropyl alcohol procured by our college.
Methods
Preparation of Co-processed Superdisintegrants
The co-processed superdisintegrants were prepared by solvent evaporation method.
Crospovidone and sodium starch glycolate (in the ratio of 1:1, 1:2, 1:3, 2:1, 3:1) were mixed together with 10 ml of isopropyl alcohol. The contents of beaker (250 ml capacity) were mixed thoroughly and stirring continue till most of isopropyl alcohol evaporated. The wet coherent mass was granulated through # 44 mesh sieve. The wet granules were dried in a hot air oven at 60º C for 20 minutes. The dried granules were sifted through # 44 mesh sieves and stored in airtight container till further use. (16, 17, 18) . (Table 1) . 
Preparation of Fast Dissolving Tablets
Fast dissolving tablets of amlodipine besylate were prepared by direct compression. All the ingredients (except granular directly compressible excipients) were passed through # 60 mesh separately. Then the ingredients were weighed and mixed in geometrical order and compressed into tablets of 150 mg using LAB PRESS compression machine with 12 compression stations and 8 mm round flat punches are used for tablet compression (Table no 2 
.1 Angle of repose
Angle of repose is defined as the maximum angle possible between the surface of a pile of the powder and horizontal plane. It is calculated by using following formula.
Tan Ѳ = h / r Ѳ = tan -1 (h/r)
Where, Ѳ is the angle of repose h is height of pile r is radius of the base of pile
Bulk Density:
Bulk density is defined as the mass of a powder divided by the bulk volume. Loose bulk density (LBD) and tapped bulk density (TBD) were determined. A quantity of accurately weighed powder was introduced into a 25 ml measuring cylinder. After the initial volume was observed, the cylinder was allowed to fall under its own weight onto a hard surface from the height of 2.5 cm at 2 sec interval. The taping was continued until no further change in volume was noted. LBD and TBD were calculated using following formula;
Tapped Density
The measuring cylinder containing a known mass of blend was tapped for a fixed time. The minimum volume (Vt) occupied in the cylinder and the weight (M) of the blend was measured.
Electrolab Tap Density Tester USP ETD-1020 is used for determination of tapped density. The tapped density (pt) was calculated using the following formula
Hausner Ratio
Hausner ratio is an indirect index of ease of power flow. It is calculated by the following formula.
Where ρ t is tapped density and ρ d is bulk density. Lower Hausner ratio (<1.25) indicates better flow properties than higher ones (>1.25).
Post compression evaluation parameters 3.2.1. Weight Variation
Twenty tablets were selected randomly from each formulation and weighed individually using a Shimadzu digital balance (BL-220H). The individual weights were compared with the average weight for the weight variation.
Thickness variation
Ten tablets from each formulation were taken randomly and their thickness was measured with a micrometer screw gauge.
Hardness and Friability
Hardness of the tablets was measured using the Monsanto Hardness Tester (Pharmalab, Ahmedabad, India). The friability of a sample of twenty tablets was measured using Roche friabilator (Pharma lab, Ahmedabad, India). Pre-weighed tablets were placed in the plastic chamber of friabilator attached to a motor revolving at a speed of 25 rpm for 4 min. The tablets were then dusted, reweighed and percentage weight loss (friability) was calculated.
Fourier Transform Infrared Spectroscopy (FTIR)
The samples of amlodipine besylate and co-processed mixture of crosspovidone and sodium starch glycolate are scanned by using Model ALPHA Brucker ECO-ATR. The scanning range was from 4000-400 cm -1 .
Drug Content Uniformity.
For the content uniformity test, ten tablets were weighed and pulverized to a fine powder, a quantity of powder equivalent to 10 mg of amlodipin besylate was extracted into distilled water and liquid was filtered (0.22 µm membrane filter disc. The amlodipin besylate content was determined by measuring the absorbance at 235.7 nm (using UV-vis spectrophotometer, Shimadzu 1700) after appropriate dilution with distilled water. The drug content was determined using standard calibration curve. The mean percent drug content was calculated as an average of three determinations. (21) 
In Vitro Dispersion Time
One tablet was placed in a beaker containing 10 ml of pH 6.8 phosphate buffers at 37 ± 0.5ºC and the time required for complete dispersion was determined.
Wetting Time and Water Absorption Ratio (R)
Twice folded tissue paper was placed in a Petri dish having an internal diameter of 5 cm containing 6 ml of water. A tablet was carefully placed on the surface of the tissue paper in the Petri dish. The time required for water to reach the upper surface of the tablet and to completely wet it was noted as the wetting time. Water absorption ratio (R) was then determined according to the following equation:
R = 100 x (Wa -Wb)/ Wb
Where;
Wb and Wa were tablet weights before and after water absorption, respectively.
In Vitro Drug Release Study
In vitro dissolution studies of the promising fast dissolving tablets of amlodipin besylate, all formulations were performed according to USP XXIII Type-II dissolution apparatus employing a paddle stirrer at 50 rpm using 900 ml of pH 6.8 phosphate buffers at 37±0.5ºC as dissolution medium.
One tablet was used in each test. Aliquots of the dissolution medium (5 ml) were withdrawn at specific time intervals ( 
Stability Studies
The promising formulations were subjected to short term stability study by storing the formulations at 40°C/75% RH up to three month. The formulations PM1 PM5 CP1 CP5 were selected.
After one month the tablets were again analyzed for the hardness, friability, drug content uniformity 
RESULTS AND DISCUSSION
Drug polymer interaction study
IR spectra for pure drug and formulations were recorded in an infrared (IR) spectrophotometer (Model ALPHA Brucker ECO-ATR) FTIR studies revealed that amlodipine besylate bands at 3016 cm-1 due to C-H stretching vibration and a band at 2980 cm-1 due to Ar-H stretching, and characteristics bands at 1696 N-H stretching and 1653 cm-1 assigned to C=C stretching.C-O stretching at 1308 cm-1 and C-Cl stretch at 754 cm-1.No significant shifts of reduction in intensity of the FTIR bands of amlodipine besylate were observed as shown in figure 1 .
DSC analyses were performed in order to evaluate possible solid-state interactions between the components and, consequently, to assess the actual drug-excipient compatibility in all the examined formulations. The thermal curves of pure components and those of some representative ternary systems are shown in Fig 2,3 . Thermograms of pure amlodipine besylate showed sharp endothermic peak at 217.95 °C. (Fig. 2 )Similar peaks were obtained in the prepared drug-polymer mixtures at 213.3°C. (Fig. 3) . This clearly indicated the nil drug polymer interaction. 
PRE COMPRESSION STUDIES A) Angle of repose (Ѳ):
The data obtained from angle of repose for superdisintigrant mixture and all the formulations were found to be in the range of 21.53333±0.85049to 29.22±0.416 and 22.5±0.926 to 29.5 ±1.023 respectively. All the formulations prepared by both the methods showed the angle of repose less than 30°, which reveals good flow property. (Table no 3 
C) Hausner's ratio:
Hausner's ratio of superdisintigrant and entire formulation showed between 1.177133±0.014162 to 1.2158±0.024301 and 1.142±0.019 to 1.177±0.019 respectively which indicates better flow properties.
D) Carr's consolidation index:
The results of Carr's consolidation index or compressibility index (%) for superdisintigant and the entire formulation blend ranged from 12.47667±0.365559% to 15.00667±0.339755%. and 12.90±2.985 to 14.52±1.25. 
POST COMPRESSION STUDIES A) Hardness:
The hardness of all the tablets prepared by both methods was maintained within the 
B) Friability test:
The friability was found in all designed formulations in the range 0.506667±0.025166 to 0.746667±0.025019 to be well within the approved range (< 1 %) .The friability study results were tabulated in table no.5
C) Weight variation test:
The weight variation was found in all designed formulations in the range 150.128±0.405941 to 150.379±0.459528 mg. The mean weight variation test results are tabulated in table no.6
D) Thickness:
The mean thickness was (n=3) almost uniform in all the formulations and values ranged from3.3033±0.04509 mm to 3.476±0.05116 mm. The results of thickness for tablets were shown in table no.5
E) In vitro dispersion time:
The in vitro dispersion time is measured by the time taken to undergo uniform dispersion.
Rapid dispersion within several minutes was observed in all the formulations. The in-vitro dispersion data is tabulated in the table no.5 
G) Water absorption ratio:
The values of water absorption ratio shown in 
H) Drug Content:
The drug content uniformity was performed for all the 11 formulations and results are tabulated in 
DISSOLUTION STUDY
Dissolution study of amlodipine besylate was carried out in phosphate buffer 6. 
